Loading clinical trials...
Loading clinical trials...
The objective of this study was to prove the bioequivalence of Roxane Laboratories' Oxcarbazepine Suspension 600 mg under fed conditions
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Roxane Laboratories
NCT05077904 · Stereotypical Prolonged Seizures
NCT06388707 · Drug Resistant Epilepsy, Epilepsy, and more
NCT07130786 · Seizures, Primary Motor Cortex, and more
NCT05667142 · Primary Generalized Tonic-Clonic Seizures
NCT07234695 · Down Syndrome, Down Syndrome (DS), and more
Worldwide Clinical Trials Drug Development Solutions (formerly CEDRA Clinical Research)
San Antonio, Texas
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions